iNtRON Biotechnology, Inc. (048530.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩3,050 (+0.00%) as of
Key statistics
- Market cap
- 94.22B
- Dividend yield
- 0.00%
- 52-week range
- 2,250.00 – 7,010.00
- Beta
- 0.10
- Revenue (TTM)
- 5.74B
- Profit margin
- -156.06%
- Volume
- 313.69k
About iNtRON Biotechnology, Inc.
iNtRON Biotechnology, Inc. engages in the development of novel biopharmaceutical drugs in South Korea. It develops bacteriophage and endolysin based drugs through itLysin and IMPA platform. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Seongnam-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.